MUC5AC and inflammatory bowel disease: Akkermansia, a mucin-degrading bacterium, regulates host barrier function and immune response, highlighting its anti-inflammatory effects and its potential as a promising strategy for the therapy of inflammatory bowel disease by addressing reduced intestinal colonization that contributes to the development of such diseases (22).